يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"antiemetic agent/dt [Drug Therapy]"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
    Journal of Pharmacy Practice and Research
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
    Journal of Pharmacy Practice and Research
    LibKey Link

  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني
  5. 5
    مورد إلكتروني
  6. 6
    مورد إلكتروني
  7. 7
  8. 8
  9. 9
    مورد إلكتروني

    مصطلحات الفهرس: drug half life, drug intoxication/di [Diagnosis], drug intoxication/et [Etiology], drug solubility, electrocardiogram, follow up, heart arrhythmia/co [Complication], hemodialysis, hemofiltration, hemoperfusion, human, hypersensitivity reaction/di [Diagnosis], hypersensitivity reaction/si [Side Effect], hypotension/co [Complication], intensive care unit, nausea, nystagmus, peripheral neuropathy/si [Side Effect], peritoneal dialysis, plasmapheresis, priority journal, respiration depression/co [Complication], review, risk factor, seizure/co [Complication], seizure/dt [Drug Therapy], stomach emptying, stomach lavage, symptom, trigeminus neuralgia/dt [Drug Therapy], vomiting/dt [Drug Therapy], acetylsalicylic acid/cb [Drug Combination], acetylsalicylic acid/it [Drug Interaction], activated carbon, anticonvulsive agent/ae [Adverse Drug Reaction], anticonvulsive agent/cb [Drug Combination], anticonvulsive agent/cr [Drug Concentration], anticonvulsive agent/do [Drug Dose], anticonvulsive agent/it [Drug Interaction], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/to [Drug Toxicity], anticonvulsive agent/iv [Intravenous Drug Administration], anticonvulsive agent/po [Oral Drug Administration], anticonvulsive agent/pr [Pharmaceutics], anticonvulsive agent/pk [Pharmacokinetics], anticonvulsive agent/pd [Pharmacology], antiemetic agent/dt [Drug Therapy], antineoplastic agent/cb [Drug Combination], antineoplastic agent/it [Drug Interaction], azapropazone/cb [Drug Combination], azapropazone/it [Drug Interaction], benzodiazepine derivative/dt [Drug Therapy], carbamazepine/cb [Drug Combination], carbamazepine/it [Drug Interaction], chlordiazepoxide/cb [Drug Combination], chlordiazepoxide/it [Drug Interaction], cotrimoxazole/cb [Drug Combination], cotrimoxazole/it [Drug Interaction], diazepam/cb [Drug Combination], diazepam/it [Drug Interaction], diltiazem/cb [Drug Combination], diltiazem/it [Drug Interaction], fluconazole/cb [Drug Combination], fluconazole/it [Drug Interaction], imipramine/cb [Drug Combination], imipramine/it [Drug Interaction], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], itraconazole/cb [Drug Combination], itraconazole/it [Drug Interaction], losartan/cb [Drug Combination], losartan/it [Drug Interaction], miconazole/cb [Drug Combination], miconazole/it [Drug Interaction], paroxetine/cb [Drug Combination], paroxetine/it [Drug Interaction], phenobarbital/dt [Drug Therapy], phenytoin/ae [Adverse Drug Reaction], phenytoin/ad [Drug Administration], phenytoin/cb [Drug Combination], phenytoin/cr [Drug Concentration], phenytoin/do [Drug Dose], phenytoin/to [Drug Toxicity], phenytoin/iv [Intravenous Drug Administration], phenytoin/po [Oral Drug Administration], phenytoin/pr [Pharmaceutics], phenytoin/pk [Pharmacokinetics], phenytoin/pd [Pharmacology], pyridoxine/cb [Drug Combination], pyridoxine/it [Drug Interaction], ranitidine/cb [Drug Combination], ranitidine/it [Drug Interaction], thioridazine/cb [Drug Combination], thioridazine/it [Drug Interaction], tolbutamide/cb [Drug Combination], tolbutamide/it [Drug Interaction], unindexed drug, valproic acid/cb [Drug Combination], valproic acid/it [Drug Interaction], verapamil/cb [Drug Combination], verapamil/it [Drug Interaction], vigabatrin/cb [Drug Combination], vigabatrin/it [Drug Interaction], viloxazine/cb [Drug Combination], viloxazine/it [Drug Interaction], QT prolongation, phenytoin/it [Drug Interaction], aspiration, behavior disorder/dt [Drug Therapy], bipolar disorder/dt [Drug Therapy], cerebellum atrophy/co [Complication], cerebellum atrophy/et [Etiology], cerebellum atrophy/si [Side Effect], clinical feature, coma, confusion, convulsion/dt [Drug Therapy], differential diagnosis, drug formulation, Review

    URL: Click here for full text options
    LibKey Link

  10. 10
    مورد إلكتروني